Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
74 /100
HIGH RISK
Score updated Aug 28, 2026

TOVX — Theriva Biologics, Inc. Dilution Risk Tracker

Track TOVX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TOVX — Get alerts when the score changes →

As of August 28, 2026, Theriva Biologics, Inc. (TOVX) has a DilutionWatch DilutionScore of 74/100, rated HIGH dilution risk. Theriva Biologics, Inc. has a market capitalization of $13.02M, 45.89M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include 13.67M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
20
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 47%
🔄 Reverse Split model est. 65%
• 50-day avg $0.29 below $1 exchange minimum
• 10 months cash with weak price
📜 Warrant Exercise model 40%
• Significant warrants: 30% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track TOVX — Get forecast alerts →

Market Data

Market Cap$13.02M
Shares Outstanding45.89M
Float45.14M
Cash$14.20M
Debt$1.73M
Short InterestN/A

Institutional Holdings

10 institutional holders · 1.17M shares
#1 Vanguard Group Inc 255.7K shares
#2 Geode Capital Management, LLC 212.1K shares
#3 Morgan Stanley 200.0K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.12M
Days to Cover4.2
% of Float4.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2024-06-30
8-K 8K EVENT 2026-06-05
8-K 8K EVENT 2026-04-09
8-K 8K EVENT 2026-02-12
Full SEC filing analysis available with free account

Recent News

No recent news

Factual TOVX Dilution Snapshot

Theriva Biologics, Inc. (TOVX) has a DilutionScore of 74/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track TOVX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TOVX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TOVX
TOVX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.